Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Gets FDA Approval for Zepbound
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
Eli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea in Adults With Obesity
Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and only prescription medicine for those suffering from this condition.
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.
2h
Zepbound helps shed more weight than Wegovy, Eli Lilly study says
A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.
45m
FDA Approves Lilly's Zepbound To Treat Obstructive Sleep Apnea In Adults With Obesity
The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
House passes funding bill
Car rams crowd in Germany
Accused of misconduct
Sentenced to 130 years
Proposes missile duel w/ US
US deportations surge
Shooter can't withdraw plea
Plans to sue accuser
Billboard campaign in MX
Egg prices hit record
'Healthy' definition updated
Crypto hacks soar to $2.2B
More student loans canceled
US diplomats visit Syria
Workers announce strike
To meet with Pope in Jan
PGA Tour Rookie of the Year
Russian missiles target Kyiv
Netflix inks deal with FIFA
GMU student charged
Announces aid for Sudan
Recalls nearly 700K vehicles
Tirzepatide shortage ends
US troops in Syria doubled
Malaysia to resume search
Norovirus risk recall
AG files to block testimony
NY temporary drone ban
76ers win stadium approval
CFPB sues top US banks
Breaks 35-year-old record
Chinese national charged
Related topics
Food and Drug Administration
Mounjaro
Feedback